Mesothelioma is a highly fatal disease with a survival rate of under 10% at five years. New advances with immunotherapy have improved survival, but only 23% of patients are alive at three years when ...

Immunotherapy cannot cure mesothelioma, but it can help you live longer. At this point in time, no one has been cured of this aggressive cancer, but advancements in diagnostics and treatment have ...

Prasad Adusumilli and colleagues have shown that CAR T cells that start to lose power can be revived by immunotherapy drugs given several weeks later. Mesothelioma is a rare cancer that affects the ...

Blockbuster cancer drug combined with chemotherapy improved survival rates in a Phase 3 trial Merck & Co. Inc. said Wednesday the U.S. Food and Drug Administration has approved its blockbuster cancer ...

Patients with mesothelioma may be getting a new second-line treatment, thanks to results from a recent immunotherapy trial. For patients with malignant pleural mesothelioma — which makes up about 90 ...

AUSTIN, Texas, April 28, 2025 /PRNewswire/ -- Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for ...

NORTH PHILADELPHIA (WPVI) -- You've probably heard of mesothelioma from commercials by law firms representing patients. However, few people really know what it is. It's a very difficult cancer, but ...

SAN MATEO, Calif., July 30, 2025 /PRNewswire/ -- Vivace Therapeutics, Inc., a small molecule discovery and development company developing first-in-class cancer therapies targeting the Hippo pathway, ...

Researchers from Rice University and Baylor College of Medicine have developed a new treatment that eliminates advanced-stage ...

Mesothelioma, a rare and aggressive cancer primarily caused by asbestos exposure, poses significant challenges not only treatment but also in the quality of life for patients and their families. Given ...